Verona Pharma

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Verona Pharma and other ETFs, options, and stocks.

About VRNA

Verona Pharma Plc operates as a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. Its lead product candidate, ensifentrine, has the potential to be the first therapy for the treatment of respiratory diseases that combines bronchodilator and anti-inflammatory activities in one compound.

CEO

David S. Zaccardelli

CEODavid S. Zaccardelli

Employees

Employees26

Headquarters

London, Greater London

HeadquartersLondon, Greater London

Founded

2005

Founded2005

Employees

Employees26

VRNA Key Statistics

Market cap

765.82M

Market cap765.82M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

227.63K

Average volume227.63K

High today

$10.68

High today$10.68

Low today

$10.22

Low today$10.22

Open price

$10.50

Open price$10.50

Volume

123.88K

Volume123.88K

52 Week high

$14.69

52 Week high$14.69

52 Week low

$3.41

52 Week low$3.41

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

VRNA Earnings

-$0.48

-$0.27

-$0.05

$0.16

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 8, Pre-Market

ActualExpected Nov 8, Pre-Market